A shorter symptom-onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: A real-world analysis

Ravindra M Mehta, Sameer Bansal, Suhitha Bysani, Hariprasad Kalpakam
doi: https://doi.org/10.1101/2020.11.05.20226373

Data Availability

The de-identified data that support the findings of this study are available from the corresponding author (RMM) upon reasonable request.

Back to top
Posted November 10, 2020.
Download PDF

Supplementary Material

Data/Code
Email
A shorter symptom-onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: A real-world analysis
Ravindra M Mehta, Sameer Bansal, Suhitha Bysani, Hariprasad Kalpakam
medRxiv 2020.11.05.20226373; doi: https://doi.org/10.1101/2020.11.05.20226373
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area